The Russian vaccine Sputnik’s effectiveness in the trial is 92 percent

The results of the final trial of the Russian Sputnik vaccine have been published in the medical journal Lancet. It is said that the Russian vaccine is 92 percent effective in the fight against the coronavirus and Sputnik is considered safe. Sputnik is also said to be fully effective in protecting corona victims.

The introduction of the vaccine before the results of the final trial was announced sparked controversy. The effectiveness and safety of the Russian vaccine are now in front of everyone, say those concerned.

  Learn about the COVID-19 pandemic from News Hour  

In the meantime, Sputnik, Pfizer, Oxford-AstraZeneca, Moderna, and Janssen came to the fore.

The Russian vaccine Sputnik V works in the same way as the Oxford-AstraZeneca vaccine made in the United States and the Janssen vaccine made in Belgium.

Follow News Hour
News Hour Correspondent

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments
Scroll Up
%d bloggers like this: